{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Optional Homework #1\n",
    "\n",
    "For anyone looking to try out their skills, try one or all of these exercises:\n",
    "\n",
    "Start with the data file: \"clinical_trial_data.json\" or the in-memory version of the data, as generated by the Jupyter Notebook \"Clinical Trial Data Extraction.ipynb\""
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Exercise 1\n",
    "Each of the clinical trials listed includes some standard text headers such as \"Summary\", \"Keywords\", \"You can join if...\" For this task, you will need to remove these standard headers from the data structure."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Automatic pdb calling has been turned ON\n"
     ]
    }
   ],
   "source": [
    "import re, json\n",
    "%pdb\n",
    "\n",
    "filename = 'clinical_trial_data.json'\n",
    "# return from data is a dict of {topic, ['header tag': [['topic', 'title', 'url', list_of_full_text], ...]}\n",
    "# data[key].append([key, sub_condition_name, study_name, study_link, study_data])\n",
    "\n",
    "# filename = '__data_export.json'  # provided you have downloaded the full data source\n",
    "\n",
    "with open(filename, 'r') as f:\n",
    "    data = json.load(f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "phrases_to_remove = ('Summary', 'Keywords', 'You can join if...') # need to ensure these match verbatim\n",
    "\n",
    "def remove_phrases_from_line_list(a_list, phrases, inplace=False):\n",
    "    for key in data:\n",
    "        for i in data[key]:\n",
    "            _, sub_condition_name, study_name, study_data = i\n",
    "            \n",
    "            if inplace:\n",
    "                for phrase in phrases_to_remove:\n",
    "                    study_data.remove(phrase)  # slow list removal, todo build a copy sequentially to speed up\n",
    "                return None\n",
    "\n",
    "            # remove lines/phrases that are known standard text headers\n",
    "            tmp = []\n",
    "            for line in study_data:\n",
    "                if line in phrases_to_remove:\n",
    "                    continue\n",
    "                tmp.append(line)\n",
    "            return tmp"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Excercise 2\n",
    "The clinical trial text data is currently stored line by line (ie - anytime there is a carriage return/newline create a new element in the text data list), but not necessarily sentence by sentence (ie - anytime there is a natural end to a sentence (period, exclamation point, etc) create a new element in the text data list). For each trial, merge the lines, then use SPACY or NLTK to split the lines by sentence. This will create a more \"NLP friendly\" dataset. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "import nltk\n",
    "def join_and_sent_segment(a_list):\n",
    "    longstr = '\\n'.join(a_list)\n",
    "    return nltk.sent_tokenize(longstr) # potentially use colons as sentence tokens as well?"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Exercise 3\n",
    "Because there is a section that includes pre-built keywords, and these keywords are important (and a varying token length), it would be helpful to 'set them aside'.  Build a new data structure that separates the keywords out from the rest of the raw text data and saves them in a list, alongside the other clinical trial level meta-data (ie-trial link, trial name, etc)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "\"\"\"\n",
    "better idea:\n",
    "use a default-dict instead of a data class\n",
    "properties are keys, values are lists of lines\n",
    "\n",
    "creation involves looping over lines and searching for matched prop-label patterns\n",
    "if a line matches, store that prop in the dict\n",
    "store the remaining lines in an 'unlabeled_lines' property\n",
    "\"\"\"\n",
    "from collections import defaultdict\n",
    "\n",
    "from tqdm import tqdm\n",
    "\n",
    "class MyDefaultDict(defaultdict):\n",
    "    \"\"\"a default dict with dot access for keys\"\"\"\n",
    "    # see https://stackoverflow.com/questions/2352181/how-to-use-a-dot-to-access-members-of-dictionary\n",
    "    # can access/set/get/delete properties with dot notation, and new properties default to None\n",
    "    __getattr__ = defaultdict.get\n",
    "    __setattr__ = defaultdict.__setitem__\n",
    "    __delattr__ = defaultdict.__delitem__\n",
    "    \n",
    "\n",
    "class StudyData(MyDefaultDict):\n",
    "    \"\"\"a container for clinical trial data and metadata\"\"\"\n",
    "    # NOTE: subclassing default dict like this means accessing nonexistent properties no longer throws an error\n",
    "    \n",
    "    PROP_REGEX = {\n",
    "        'topic': 'Topic:',\n",
    "        'subtopic': 'subtopic:',\n",
    "        'title': 'Title:',\n",
    "        'url': 'Link:',\n",
    "        'summary': 'Summary',\n",
    "        'official_title': 'Official Title',\n",
    "        'keywords': 'Keywords',\n",
    "        'eligibility_criteria_pos': ' You can join ifâ€¦ ',\n",
    "        'eligibility_criteria_neg': \" You CAN'T join if... \",\n",
    "        'principal_investigators': 'Principal Investigators:',\n",
    "        'study_design': 'Study Design:',\n",
    "        'eligibility': 'Eligibility', # section header, will not contain any data\n",
    "        'details': 'Details', # section header, will not contain any data\n",
    "\n",
    "    }\n",
    "\n",
    "    \n",
    "    @classmethod \n",
    "    def parse_fulltext(cls, list_of_str, progbar=True):\n",
    "        \"\"\"parses a list of strings into a defaultdict of field: [lines] based on fields defined in PROP_REGEX\"\"\"\n",
    "        prop_label = None\n",
    "        prop_items = []\n",
    "        properties_list = MyDefaultDict()\n",
    "        unlabeled_lines = []\n",
    "        # loop over the lines in the full text\n",
    "        for line in (tqdm(list_of_str, desc='Parsing fulltext') if progbar else list_of_str):\n",
    "            for k, v in cls.PROP_REGEX.items():\n",
    "                # if any line matches a property tag, set the flag to save the subsequent lines\n",
    "                if re.match(v, line):\n",
    "                    if prop_label and prop_items:  # save only labels with following line items\n",
    "                        properties_list[prop_label] =  prop_items if len(prop_items) > 1 else prop_items[0]\n",
    "                    prop_label = k\n",
    "                    prop_items = []\n",
    "                    break\n",
    "            else:\n",
    "                # no match, save the subsequent lines\n",
    "                if prop_label:\n",
    "                    prop_items.append(line)\n",
    "                else:\n",
    "                    unlabeled_lines.append(line)\n",
    "        # save the final list if applicable\n",
    "        if prop_label:\n",
    "            properties_list[prop_label] = prop_items\n",
    "        if unlabeled_lines:\n",
    "            properties_list['unlabeled_lines'] = unlabeled_lines\n",
    "        return properties_list\n",
    "                \n",
    "    \n",
    "    def __init__(self, fulltext=[], **kwargs):\n",
    "        self.topic = None\n",
    "        self.subtopic = None\n",
    "        self.title = None\n",
    "        self.url = None\n",
    "        self.fulltext = fulltext\n",
    "        self.misc_props = dict()  # supports arbitrary miscellaneous properties\n",
    "        self.data = self.parse_fulltext(fulltext)\n",
    "        for i in kwargs:\n",
    "            if hasattr(self, i):\n",
    "                setattr(self, i, kwargs[i])\n",
    "            else:\n",
    "                self.misc_props[i] = kwargs[i]\n",
    "    \n",
    "    \n",
    "#     def __str__(self):\n",
    "#         out = str(super.__str__(self)) + '\\n'\n",
    "#         out += 'topic: {}\\nsubtopic: {}\\ntitle: {}\\nurl: {}\\n'.format(topic, subtopic, title, url)\n",
    "#         out += '\\n'.join(['{}: {}'.format(k, v) \n",
    "#                           for k,v in self.misc_props.items()]) + '\\n'\n",
    "#         out += '\\n'.join(['{}: {}'.format(k, v) \n",
    "#                           for k,v in self.data.items()])\n",
    "#         return out.strip(' \\n')\n",
    "\n",
    "                \n",
    "    "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "todo list:\n",
    "    - Find a list of:\n",
    "        - known structure tags (you can join if..., eligibility, keywords, ...)\n",
    "            - flatten everything\n",
    "            - count occurrances\n",
    "            - drop unique terms\n",
    "        - abbreviations (see below)\n",
    "        - total vocabulary\n",
    "    - Expand abbreviations ('orbital occlusion (OO)... OO measures ...')\n",
    "    - Impute structure from tags (vs treat everything as text blob, but maintain linebreaks as delimiters)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "# data structure is a dict of {'topic': [['topic', 'subtopic', 'title', 'url', list_of_full_text], ...]}\n",
    "\n",
    "# data[key].append([key, sub_condition_name, study_name, study_link, study_data])\n",
    "def print_str_items(iterable, prefix=''):\n",
    "    len_cutoff = 80\n",
    "    indent = 2\n",
    "    for i in iterable:\n",
    "        if isinstance(i, str):\n",
    "            print(prefix + (i[:len_cutoff] + '...' if len(i) > len_cutoff else i))\n",
    "        else:\n",
    "            print(prefix)\n",
    "            print_str_items(i, prefix + ' '*indent + '|')\n",
    "# print_str_items(data['cancer'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Parsing fulltext: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 46/46 [00:00<00:00, 19425.89it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "defaultdict(None, {'topic': 'cancer', 'subtopic': 'Acute Lymphoblastic Leukemia', 'title': 'A Multi-Center Study Evaluating KTE-C19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia', 'url': 'https://clinicaltrials.ucsf.edu/trial/NCT02625480', 'fulltext': ['Summary', 'This is a single arm, open-label, multi-center, phase 1/2 study, to determine the safety and efficacy of KTE-C19, an autologous anti-CD19 chimeric antigen receptor (CAR)-positive T cell therapy, in relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL) in pediatric or adolescent subjects.', 'Official Title', 'A Phase 1-2 Multi-Center Study Evaluating the Safety and Efficacy of KTE C19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) (ZUMA-4)', 'Keywords', 'Acute Lymphoblastic Leukemia', 'Leukemia', 'Precursor Cell Lymphoblastic Leukemia-Lymphoma', 'Leukemia, Lymphoid', 'KTE-C19', 'Eligibility', ' You can join ifâ€¦ ', 'Open to people ages 2-21', ' Relapsed or refractory B-precursor ALL defined as one of the following:', ' Primary refractory disease', ' Relapsed or refractory disease after first or later salvage therapy', ' Relapsed or refractory disease after allogeneic transplant provided subject is at least 100 days from stem cell transplant at the time of enrollment', ' Morphological disease in the bone marrow (â‰¥ 5% blasts)', ' Subjects with Ph+ disease are eligible if they are intolerant to tyrosine kinase inhibitor (TKI) therapy, or if they have relapsed/refractory disease despite treatment with at least 2 different TKIs', ' Ages 2 to 21 at the time of Assent or Consent per IRB guidelines', ' Lansky (age < 16 years at the time of assent/consent) or Karnofsky (age â‰¥ 16 years at the time of assent/consent) performance status â‰¥ 80 at screening', ' Adequate renal, hepatic, pulmonary and cardiac function defined as:', ' Creatinine clearance â‰¥ 60 cc/min', ' Serum ALT/AST â‰¤ 2.5 x ULN', ' Total bilirubin â‰¤ 1.5 x ULN', ' Cardiac ejection fraction â‰¥ 50% and no clinically significant ECG findings', ' Baseline oxygen saturation > 92% on room air', \" You CAN'T join if... \", \" Diagnosis of Burkitt's leukemia/lymphoma according to WHO classification or chronic myelogenous leukemia lymphoid blast crisis\", ' History of malignancy other than non-melanoma skin cancer or carcinoma in situ (e.g.cervix, bladder, breast) unless disease free for at least 3 years', ' Presence of CNS-3 disease and CNS-2 disease with neurological changes', ' History of concomitant genetic syndrome such as Fanconi anemia, Kostmann syndrome,Shwachman-Diamond syndrome or any other known bone marrow failure syndrome', ' History of myocardial infarction, cardiac angioplasty or stenting, unstable angina, or other clinically significant cardiac disease within 12 months of enrollment', ' History of symptomatic deep vein thrombosis or pulmonary embolism within 6 months of enrollment.', ' Primary immunodeficiency', ' Known infection with HIV, hepatitis B (HBsAg positive) or hepatitis C virus (anti-HCV positive)', ' Presence of fungal, bacterial, viral, or other infection that is uncontrolled or requiring IV antimicrobials for management.', '. Prior medication:', ' Prior CD19 directed therapy, including CAR+ T cell, BiTE, and antibody drug conjugate (ADC), with the exception of subjects who received KTE-C19 in this study and are eligible for re-treatment', ' Treatment with alemtuzumab within 6 months prior to leukapheresis, or treatment with clofarabine or cladribine within 3 months prior to leukapheresis', ' Donor lymphocyte infusion (DLI) within 28 days prior to enrollment', ' Any drug used for GVHD within 4 weeks prior to enrollment', '. Acute GVHD grade II-IV by Glucksberg criteria or severity B-D by IBMTR index; acute or chronic GVHD requiring systemic treatment within 4 weeks prior to enrollment', '. Live vaccine â‰¤ 6 weeks prior to start of conditioning regimen', '. Women of child-bearing potential who are pregnant or breastfeeding because of the potentially dangerous effects of the preparative chemotherapy on the fetus or infant.Females who have undergone surgical sterilization are not considered to be of childbearing potential', '. Subjects of both genders of child-bearing potential who are not willing to practice birth control from the time of consent through 6 months after the completion of KTE-C19'], 'misc_props': {}, 'data': defaultdict(None, {'summary': 'This is a single arm, open-label, multi-center, phase 1/2 study, to determine the safety and efficacy of KTE-C19, an autologous anti-CD19 chimeric antigen receptor (CAR)-positive T cell therapy, in relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL) in pediatric or adolescent subjects.', 'official_title': 'A Phase 1-2 Multi-Center Study Evaluating the Safety and Efficacy of KTE C19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) (ZUMA-4)', 'keywords': ['Acute Lymphoblastic Leukemia', 'Leukemia', 'Precursor Cell Lymphoblastic Leukemia-Lymphoma', 'Leukemia, Lymphoid', 'KTE-C19'], 'eligibility_criteria_pos': ['Open to people ages 2-21', ' Relapsed or refractory B-precursor ALL defined as one of the following:', ' Primary refractory disease', ' Relapsed or refractory disease after first or later salvage therapy', ' Relapsed or refractory disease after allogeneic transplant provided subject is at least 100 days from stem cell transplant at the time of enrollment', ' Morphological disease in the bone marrow (â‰¥ 5% blasts)', ' Subjects with Ph+ disease are eligible if they are intolerant to tyrosine kinase inhibitor (TKI) therapy, or if they have relapsed/refractory disease despite treatment with at least 2 different TKIs', ' Ages 2 to 21 at the time of Assent or Consent per IRB guidelines', ' Lansky (age < 16 years at the time of assent/consent) or Karnofsky (age â‰¥ 16 years at the time of assent/consent) performance status â‰¥ 80 at screening', ' Adequate renal, hepatic, pulmonary and cardiac function defined as:', ' Creatinine clearance â‰¥ 60 cc/min', ' Serum ALT/AST â‰¤ 2.5 x ULN', ' Total bilirubin â‰¤ 1.5 x ULN', ' Cardiac ejection fraction â‰¥ 50% and no clinically significant ECG findings', ' Baseline oxygen saturation > 92% on room air'], 'eligibility_criteria_neg': [\" Diagnosis of Burkitt's leukemia/lymphoma according to WHO classification or chronic myelogenous leukemia lymphoid blast crisis\", ' History of malignancy other than non-melanoma skin cancer or carcinoma in situ (e.g.cervix, bladder, breast) unless disease free for at least 3 years', ' Presence of CNS-3 disease and CNS-2 disease with neurological changes', ' History of concomitant genetic syndrome such as Fanconi anemia, Kostmann syndrome,Shwachman-Diamond syndrome or any other known bone marrow failure syndrome', ' History of myocardial infarction, cardiac angioplasty or stenting, unstable angina, or other clinically significant cardiac disease within 12 months of enrollment', ' History of symptomatic deep vein thrombosis or pulmonary embolism within 6 months of enrollment.', ' Primary immunodeficiency', ' Known infection with HIV, hepatitis B (HBsAg positive) or hepatitis C virus (anti-HCV positive)', ' Presence of fungal, bacterial, viral, or other infection that is uncontrolled or requiring IV antimicrobials for management.', '. Prior medication:', ' Prior CD19 directed therapy, including CAR+ T cell, BiTE, and antibody drug conjugate (ADC), with the exception of subjects who received KTE-C19 in this study and are eligible for re-treatment', ' Treatment with alemtuzumab within 6 months prior to leukapheresis, or treatment with clofarabine or cladribine within 3 months prior to leukapheresis', ' Donor lymphocyte infusion (DLI) within 28 days prior to enrollment', ' Any drug used for GVHD within 4 weeks prior to enrollment', '. Acute GVHD grade II-IV by Glucksberg criteria or severity B-D by IBMTR index; acute or chronic GVHD requiring systemic treatment within 4 weeks prior to enrollment', '. Live vaccine â‰¤ 6 weeks prior to start of conditioning regimen', '. Women of child-bearing potential who are pregnant or breastfeeding because of the potentially dangerous effects of the preparative chemotherapy on the fetus or infant.Females who have undergone surgical sterilization are not considered to be of childbearing potential', '. Subjects of both genders of child-bearing potential who are not willing to practice birth control from the time of consent through 6 months after the completion of KTE-C19']})})\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    }
   ],
   "source": [
    "topic, subtopic, title, url, dt = data['cancer'][0]\n",
    "b = StudyData(topic=topic, subtopic=subtopic, title=title, url=url, fulltext=dt)\n",
    "print(b)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
